T. Rowe Price Associates’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $689K | Buy |
62,432
+1,588
| +3% | +$17.5K | ﹤0.01% | 2149 |
|
|
2025
Q1 | $544K | Sell |
60,844
-3,951
| -6% | -$35.3K | ﹤0.01% | 2217 |
|
|
2024
Q4 | $610K | Buy |
64,795
+9,315
| +17% | +$87.7K | ﹤0.01% | 2192 |
|
|
2024
Q3 | $448K | Buy |
55,480
+7,700
| +16% | +$62.2K | ﹤0.01% | 2295 |
|
|
2024
Q2 | $406K | Sell |
47,780
-1,695
| -3% | -$14.4K | ﹤0.01% | 2277 |
|
|
2024
Q1 | $444K | Buy |
49,475
+3,532
| +8% | +$31.7K | ﹤0.01% | 2255 |
|
|
2023
Q4 | $517K | Sell |
45,943
-2,080
| -4% | -$23.4K | ﹤0.01% | 2150 |
|
|
2023
Q3 | $415K | Buy |
48,023
+5,043
| +12% | +$43.6K | ﹤0.01% | 2197 |
|
|
2023
Q2 | $445K | Buy |
42,980
+5,064
| +13% | +$52.4K | ﹤0.01% | 2189 |
|
|
2023
Q1 | $412K | Buy |
37,916
+948
| +3% | +$10.3K | ﹤0.01% | 2190 |
|
|
2022
Q4 | $415K | Sell |
36,968
-43,609
| -54% | -$490K | ﹤0.01% | 2218 |
|
|
2022
Q3 | $818K | Buy |
80,577
+9,264
| +13% | +$94K | ﹤0.01% | 1860 |
|
|
2022
Q2 | $646K | Buy |
71,313
+25,905
| +57% | +$235K | ﹤0.01% | 2102 |
|
|
2022
Q1 | $434K | Buy |
45,408
+4,347
| +11% | +$41.5K | ﹤0.01% | 2391 |
|
|
2021
Q4 | $454K | Sell |
41,061
-9,500
| -19% | -$105K | ﹤0.01% | 2426 |
|
|
2021
Q3 | $374K | Buy |
50,561
+14,724
| +41% | +$109K | ﹤0.01% | 2494 |
|
|
2021
Q2 | $520K | Sell |
35,837
-1,937
| -5% | -$28.1K | ﹤0.01% | 2371 |
|
|
2021
Q1 | $771K | Sell |
37,774
-408,677
| -92% | -$8.34M | ﹤0.01% | 2170 |
|
|
2020
Q4 | $7.93M | Sell |
446,451
-97,929
| -18% | -$1.74M | ﹤0.01% | 1383 |
|
|
2020
Q3 | $8.05M | Buy |
544,380
+19,919
| +4% | +$295K | ﹤0.01% | 1343 |
|
|
2020
Q2 | $11M | Buy |
524,461
+9,992
| +2% | +$210K | ﹤0.01% | 1275 |
|
|
2020
Q1 | $11.9M | Sell |
514,469
-11,969
| -2% | -$277K | ﹤0.01% | 1198 |
|
|
2019
Q4 | $13.6M | Buy |
526,438
+2,424
| +0.5% | +$62.8K | ﹤0.01% | 1261 |
|
|
2019
Q3 | $10.2M | Sell |
524,014
-615,356
| -54% | -$12M | ﹤0.01% | 1284 |
|
|
2019
Q2 | $18.6M | Sell |
1,139,370
-71,609
| -6% | -$1.17M | ﹤0.01% | 1193 |
|
|
2019
Q1 | $27.5M | Sell |
1,210,979
-22,083
| -2% | -$501K | ﹤0.01% | 1076 |
|
|
2018
Q4 | $31.6M | Sell |
1,233,062
-363,125
| -23% | -$9.29M | 0.01% | 985 |
|
|
2018
Q3 | $52.1M | Sell |
1,596,187
-144,593
| -8% | -$4.72M | 0.01% | 904 |
|
|
2018
Q2 | $39.5M | Sell |
1,740,780
-604,415
| -26% | -$13.7M | 0.01% | 976 |
|
|
2018
Q1 | $56.9M | Buy |
2,345,195
+29,655
| +1% | +$719K | 0.01% | 822 |
|
|
2017
Q4 | $64.6M | Buy |
2,315,540
+15,244
| +0.7% | +$425K | 0.01% | 768 |
|
|
2017
Q3 | $78.8M | Buy |
2,300,296
+980,855
| +74% | +$33.6M | 0.01% | 694 |
|
|
2017
Q2 | $52.6M | Buy |
1,319,441
+956,706
| +264% | +$38.1M | 0.01% | 800 |
|
|
2017
Q1 | $13.4M | Buy |
362,735
+74,370
| +26% | +$2.74M | ﹤0.01% | 1270 |
|
|
2016
Q4 | $9.19M | Sell |
288,365
-26,958
| -9% | -$859K | ﹤0.01% | 1331 |
|
|
2016
Q3 | $11.4M | Buy |
315,323
+104,560
| +50% | +$3.79M | ﹤0.01% | 1285 |
|
|
2016
Q2 | $4.78M | Buy |
210,763
+87,200
| +71% | +$1.98M | ﹤0.01% | 1405 |
|
|
2016
Q1 | $2.32M | Sell |
123,563
-12,790
| -9% | -$240K | ﹤0.01% | 1492 |
|
|
2015
Q4 | $2.24M | Sell |
136,353
-3,822
| -3% | -$62.6K | ﹤0.01% | 1515 |
|
|
2015
Q3 | $1.54M | Buy |
140,175
+15,490
| +12% | +$170K | ﹤0.01% | 1591 |
|
|
2015
Q2 | $1.62M | Buy |
124,685
+700
| +0.6% | +$9.11K | ﹤0.01% | 1630 |
|
|
2015
Q1 | $2.15M | Sell |
123,985
-218,963
| -64% | -$3.8M | ﹤0.01% | 1573 |
|
|
2014
Q4 | $5.12M | Sell |
342,948
-2,097
| -0.6% | -$31.3K | ﹤0.01% | 1457 |
|
|
2014
Q3 | $7.95M | Buy |
345,045
+241,149
| +232% | +$5.56M | ﹤0.01% | 1364 |
|
|
2014
Q2 | $3.31M | Buy |
+103,896
| New | +$3.31M | ﹤0.01% | 1505 |
|